50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Darden Profits, Moderna OK, Fed Speech: 3 Things to Watch

Published 12/17/2020, 03:37 PM
Updated 12/17/2020, 03:43 PM
©  Reuters

By Liz Moyer

Investing.com -- The S&P 500 and NASDAQ Composite reached new records on Thursday as Congress inched closer to agreement on a $900 billion economic rescue package.

Talks on Capitol Hill continued after new data showed that the number of Americans filing for unemployment assistance jumped to a three-month high last week, well above estimates.

Weakness in the labor market, combined with new business shutdowns across the nation to stop the spread of the coronavirus, is putting even more pressure on lawmakers to get a stimulus deal done before they leave for the holiday break.

Vaccines continue to be delivered despite a storm that blanketed the Northeast U.S. with heavy snow, with some parts of central New York buried under three feet of it. The Food and Drug Administration could approve Moderna’s vaccine by Friday.

Here are three things that could affect markets tomorrow:

1. Earnings from Darden and Nike

The service industry has been hardest-hit by the pandemic, as businesses were forced to close or restrict occupancy to slow the spread of the virus. But some are doing better than others. Darden Restaurants Inc (NYSE:DRI), owner of the Olive Garden chain and others, is expected to report earnings per share of 71 cents on sales of $1.7 billion.

At the same time, casual and athletic apparel brands have done well as shut-in consumers shopped online for shoes and exercise clothing. Nike Inc (NYSE:NKE) is expected to report EPS of 62 cents on revenue of $10.5 billion.

2. Next up for vaccines

Investors cheered last week when the FDA approved a vaccine by Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for emergency use, and that vaccine has since rolled out and been put to use. On Friday, Moderna Inc (NASDAQ:MRNA) steps into the spotlight.

The Cambridge, Mass., drug maker traded up 5% on Thursday in anticipation of an FDA announcement. The shares are up 634% this year.

3. A Fed official scheduled to speak

The Federal Reserve’s Lael Brainard is scheduled to speak Friday at 11:00 AM ET (1500 GMT) on the topic of climate change and financial regulation. The appearance is hosted by the Center for American Progress.

Brainard has been an outspoken proponent of extra stimulus to support households and businesses, urging Congress to act quickly. This week, the Fed left interest rates alone and said it would support the economy until the recovery is complete.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.